id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3091-0001,FDA,FDA-2018-N-3091,"Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee;
Renewal",Notice,Renewals,2018-09-04T04:00:00Z,2018,9,2018-09-04T04:00:00Z,,2018-10-23T15:25:37Z,2018-19067,0,0,090000648369499c